These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21683089)

  • 1. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Amos B; Alkam T
    Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
    Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
    Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).
    Zhong W; Chebolu S; Darmani NA
    Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
    Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva).
    Alkam T; Chebolu S; Darmani NA
    Eur J Pharmacol; 2014 Jan; 722():156-64. PubMed ID: 24513510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
    Zhong W; Darmani NA
    Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
    Darmani NA
    J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.
    Rojas C; Slusher BS
    Eur J Pharmacol; 2012 Jun; 684(1-3):1-7. PubMed ID: 22425650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects.
    Stathis M; Pietra C; Rojas C; Slusher BS
    Eur J Pharmacol; 2012 Aug; 689(1-3):25-30. PubMed ID: 22683863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).
    Darmani NA; Henry DA; Zhong W; Chebolu S
    Behav Pharmacol; 2020 Feb; 31(1):3-14. PubMed ID: 31503071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
    Rojas C; Raje M; Tsukamoto T; Slusher BS
    Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Kim WD; Narlesky M; Adams J; Dong F
    Eur J Pharmacol; 2017 Aug; 809():20-31. PubMed ID: 28501575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (
    Belkacemi L; Sun Y; Darmani NA
    Front Pharmacol; 2022; 13():848673. PubMed ID: 35444553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Study of the Antiemetic Effects of α
    Sun Y; Darmani NA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Δ
    Darmani NA; Belkacemi L; Zhong W
    Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.